Music, Science, PARP And The Meaning Of A New Drug For Metastatic Breast Cancer With BRCA Mutations
Friday , January 19 , 2018 - 09:00 PM

So far, data from the OlympiAD trial for Lynparza in breast cancer are not impressive in a "Wow" kind of way. But the potential application of this, and other PARP inhibitors, is huge.

View Source

Corporate News